The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 348K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manis, J. P.
Right arrow Articles by Alt, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manis, J. P.
Right arrow Articles by Alt, F. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/10/1421/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 8, October 19, 1998 1421-1431


Articles

Class Switching in B Cells Lacking 3' Immunoglobulin Heavy Chain Enhancers

John P. Manis*,{ddagger}, Nienke van der Stoep*,{ddagger}, Ming Tian*,{ddagger}, Roger Ferrini*,{ddagger},§, Laurie Davidson*,{ddagger}, Andrea Bottaro§, and Frederick W. Alt*,{ddagger},§,||

From * The Howard Hughes Medical Institute and {ddagger} The Children's Hospital, Boston, Massachusetts 02115; and the § Center for Blood Research and || Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115

The 40-kb region downstream of the most 3' immunoglobulin (Ig) heavy chain constant region gene (C{alpha}) contains a series of transcriptional enhancers speculated to play a role in Ig heavy chain class switch recombination (CSR). To elucidate the function of this putative CSR regulatory region, we generated mice with germline mutations in which one or the other of the two most 5' enhancers in this cluster (respectively referred to as HS3a and HS1,2) were replaced either with a pgk-neor cassette (referred to as HS3aN and HS1,2N mutations) or with a loxP sequence (referred to as HS3a{Delta} and HS1,2{Delta}, respectively). B cells homozygous for the HS3aN or HS1,2N mutations had severe defects in CSR to several isotypes. The phenotypic similarity of the two insertion mutations, both of which were cis-acting, suggested that inhibition might result from pgk-neor cassette gene insertion rather than enhancer deletion. Accordingly, CSR returned to normal in B cells homozygous for the HS3a{Delta} or HS1,2{Delta} mutations. In addition, induced expression of the specifically targeted pgk-neor genes was regulated similarly to that of germline CH genes. Our findings implicate a 3' CSR regulatory locus that appears remarkably similar in organization and function to the β-globin gene 5' LCR and which we propose may regulate differential CSR via a promoter competition mechanism.

Key Words: immunoglobulin genes • class switching • enhancers • gene-targeted mutation • transcription


Address correspondence to Frederick W. Alt, The Howard Hughes Medical Institute, The Children's Hospital, 861, 320 Longwood Ave., Boston, MA 02115. Phone: 617-355-7290; Fax: 617-730-0432; E-mail: alt{at}rascal.med.harvard.edu

The first three authors contributed equally to this work.

Abbreviations used: CSR, class switch recombination; ES, embryonic stem; H, Ig heavy; LCR, locus control region.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS